Bacillus subtilis: safety and interactions

Tolerability of strains, infection risk, and interactions involving antibiotics and natto with medicines.

Key points

  • In people with severe illness, weakened immunity or a central venous catheter, live probiotics require individual medical assessment because of the risk of infection. This applies to probiotics in general. [1] [2] [3] [4] [5] See the evidence 1
  • In studies of MB40, constipation, abdominal discomfort, diarrhea and gas were among the possible reactions reported. Consider the tolerability of the specific product. [1] [2] [3] [4] [5] See the evidence 1
  • Some antibiotics may reduce the effect of some probiotics; check compatibility and timing with a doctor or pharmacist. If taking warfarin, discuss eating natto with a doctor: the food contains vitamin K, which affects the action of the medicine. [6] [7] [8] See the evidence 1

Practical guide

Check the findings and their applicability to your situation.

Safety depends on the person’s condition, the specific product and medicines taken.

Key points

Why these conclusions

Tolerability and interactions

At 5 billion CFU of MB40 daily, adverse events occurred in both groups; constipation, discomfort, diarrhea, gas and dry mouth were among those possibly related to the supplement. In a separate study of 10 billion CFU of MB40, the authors considered vomiting and chills in one person probably related to intake. [1] [2] [3] [4] [5]

In the R0179 study, one participant in the 10 billion CFU group withdrew after itching and skin redness; a causal relationship was not established. The FDA issued a separate warning about probiotics for hospitalized preterm infants. [1] [2] [3] [4] [5]

Some antibiotics may reduce the effect of some probiotics, depending on the medicine and strain. Natto increases vitamin K intake: people taking warfarin and similar medicines should discuss eating it with a doctor and maintain a consistent intake of the vitamin. [6] [7] [8]

Information from the source

In a study of 5 billion CFU of MB40 daily, adverse events were reported in both groups. Those possibly related to the supplement included constipation, abdominal discomfort, diarrhea, gas and dry mouth; they had resolved by the end of the study. In a separate tolerability study of 10 billion CFU of MB40 daily, one participant experienced vomiting and chills, which the authors considered probably related to intake. They resolved within 31 hours. In the R0179 study, one participant in the 10 billion CFU group discontinued after itching and skin redness; a causal relationship was not established. In people with severe illness, weakened immunity or a central venous catheter, live probiotics require individual medical assessment because of the risk of infection. The FDA issued a separate warning for hospitalized preterm infants. This information applies to probiotics in general, not to an established infection rate for each B. subtilis strain. [1] [2] [3] [4] [5]

Drug interactions

AgentInteractionWhat to considerSources
AntibioticsSome antibiotics may reduce the effect of some probiotics; this depends on the medicine and strain.Check the compatibility of the specific product and timing of intake with a doctor or pharmacist.[7]
Warfarin and similar anticoagulants: nattoNatto increases vitamin K intake. A sudden change in the amount in the diet may change the effect of warfarin and other vitamin K antagonists.Discuss eating natto with the treating doctor and maintain a consistent vitamin K intake.[6] [8]

More details

When assessment is needed

If you have a severe illness, weakened immunity or a central venous catheter, discuss a live probiotic with a healthcare professional: these conditions are associated with a risk of infection. [1] [2] [3] [4] [5]

Sources

  1. A Randomized, Double-blind, Placebo-controlled, Parallel Study Evaluating the Efficacy of Bacillus subtilis MB40 to Reduce Abdominal Discomfort, Gas, and Bloating. https://pubmed.ncbi.nlm.nih.gov/31719214/
  2. Probiotics — Health Professional Fact Sheet (NIH ODS). https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/
  3. FDA Raises Concerns About Probiotic Products Sold for Use in Hospitalized Preterm Infants. https://www.fda.gov/news-events/press-announcements/fda-raises-concerns-about-probiotic-products-sold-use-hospitalized-preterm-infants
  4. Evaluation of Bacillus subtilis R0179 on gastrointestinal viability and general wellness: a randomised, double-blind, placebo-controlled trial in healthy adults. https://pubmed.ncbi.nlm.nih.gov/25062611/
  5. Safety Assessment of Bacillus subtilis MB40 for Use in Foods and Dietary Supplements. https://pubmed.ncbi.nlm.nih.gov/33668992/
  6. Treatment of natto, a fermented soybean preparation, to prevent excessive plasma vitamin K concentrations in patients taking warfarin. https://pubmed.ncbi.nlm.nih.gov/17190098/
  7. NIH Office of Dietary Supplements: Dietary Supplements for Immune Function and Infectious Diseases — Health Professional Fact Sheet. https://ods.od.nih.gov/factsheets/Immunefunction-HealthProfessional/
  8. NIH Office of Dietary Supplements: Vitamin K — Health Professional Fact Sheet. https://ods.od.nih.gov/factsheets/VitaminK-HealthProfessional/

Methodology: Subpages evidence-led supplement pipeline v1

Ingredient overview: Bacillus subtilis